Wockhardt Limited
NSE: WOCKPHARMAINE049B01025·HealthcareSmallcap 250·www.wockhardt.com ↗·Mcap ₹37,856 Cr·Listed 2000
₹2,265.60▼ ₹22.10  (−0.97%)
52W: ₹1,087 – ₹2,422 · Vol: 6.9L shares · Close 25 Sept
Set Alert

Quarterly results

consolidated · as filed with NSE · Q1 FY27 back to Q4 FY18
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q1 FY24Q4 FY23Q3 FY23Q2 FY23Q1 FY23Q4 FY22Q3 FY22Q2 FY22Q1 FY22Q4 FY21Q3 FY21Q2 FY21Q1 FY21Q4 FY20Q3 FY20Q2 FY20Q1 FY20Q4 FY19Q3 FY19Q2 FY19Q1 FY19Q4 FY18
Revenue from operations9299658887827387437218097397007017536446786996795956558548628606327647145986878698028639791,0461,1261,0081,018
Other income314525212015893054824143225757142.15.21.77.510116.2813.717.2−0.28.15.42.16.17.4−8.4
Total expenses8448438367127707807088277759347968127628078037717488338858968678188338158007968708739491,0331,1691,1641,1151,128
EBITDA192225177178726412811091−10337721634543−16−3311195.8121−66.158.416.7−72.113.513447.739.955.6−17.867.44.5−6.1
EBITDA margin20.7%23.3%19.9%22.8%9.8%8.6%17.8%13.6%12.3%-14.7%5.3%9.6%2.5%0.4%6.4%6.3%-2.7%-5.0%13.1%11.1%14.1%-10.5%7.6%2.3%-12.0%2.0%15.4%5.9%4.6%5.7%-1.7%6.0%0.4%-0.6%
Finance costs52506055484860737373777679768370738680.169.164.154.659.960.973.761.478.764.670.963.563.665.172.765
Depreciation5553655356535555545855555556666564596261.264.36567.957.25660.956.353.45545.441.240.239.238.2
Profit before tax1161896791−109−2221−9−6−180−87−35−118−193−105−230−96−347−28.6−29.2−6−17831.2−85.1−336−95.116.4−70.6−77.9−48−121−31.8−99.9−118
Tax92569−1231710−3−1381844−3−23−21−36−30.3−66.40.6−71.3−1.2−88.4−111−144−2.823.7−41−34.1−43.7−1−4.935.2
Net profit1071646182−108−4520−16−16−177−86−73−136−237−102−207−75−3111.837.2−6.6−10732.43.376068.519.2−94.2−36.9−13.9−76.9−30.8−95.1−153
Net margin11.5%17.0%6.9%10.5%-14.6%-6.1%2.8%-2.0%-2.2%-25.3%-12.3%-9.7%-21.1%-35.0%-14.6%-30.5%-12.6%-47.5%0.2%4.3%-0.8%-16.9%4.2%0.5%127.0%10.0%2.2%-11.7%-4.3%-1.4%-7.3%-2.7%-9.4%-15.0%
EPS (₹)6.5510.233.614.81-5.53-1.570.91-1.47-0.95-11.64-5.75-5.37-9.28-14.37-6.62-13.15-4.64-21.20-0.613.03-1.15-8.381.380.32-20.342.570.87-7.42-4.06-1.31-6.42-2.06-7.79-13.97
Net profit YoY+199.1%+464.4%+205.0%+612.5%−575.0%+74.6%+123.3%+78.1%+88.2%+25.3%+15.7%+64.7%−81.3%+23.8%−5862.7%−656.9%−1039.8%−191.1%−94.5%+1029.8%−100.9%−255.9%+68.7%+103.5%+2160.1%+592.9%+125.0%−205.6%+61.2%+90.9%––––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26FY25FY24FY23FY22FY21FY20FY19FY18
Revenue from operations3,3733,0122,7982,6513,2302,7082,8444,1583,937
Other income11162831222013238.821120
Total expenses3,1613,0903,2873,1033,4783,2663,2254,4804,340
EBITDA65239339101298−631191101.8
EBITDA margin19.3%13.0%1.4%3.8%9.2%-2.3%4.2%2.6%0.0%
Finance costs213254305302299249276265255
Depreciation227217223251247246224166150
Profit before tax238−16−420−624−411−568−342−300−641
Tax394152−3−132−272−204−83.725.7
Net profit199−57−472−621−279689−43.4−217−667
Net margin5.9%-1.9%-16.9%-23.4%-8.6%25.4%-1.5%-5.2%-16.9%
EPS (₹)13.12-3.02-32.05-38.79-20.24-27.02-14.79-17.58-55.01
Net profit YoY+449.1%+87.9%+24.0%−122.6%−140.5%+1687.0%+80.0%+67.5%–
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26FY25FY24FY23FY22
Operating cash flow390−22219153413
Investing cash flow−241−783−137−125−201
Financing cash flow−54409334−315−71
Capital expenditure136945942118
Free cash flow (CFO − capex)254−116160111295

Net profit trend

annual, ₹ crore
FY21
₹689
FY22
₹−279−141%
FY23
₹−621−123%
FY24
₹−472+24%
FY25
₹−57+88%
FY26
₹199+449%

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Consolidated10 Aug 2026PDF on NSE XBRL
Q1 FY27Standalone10 Aug 2026PDF on NSE XBRL
Q4 FY26Consolidated · audited4 May 2026PDF on NSE XBRL
Q4 FY26Standalone · audited4 May 2026PDF on NSE XBRL
Q3 FY26Consolidated10 Feb 2026PDF on NSE XBRL
Q3 FY26Standalone10 Feb 2026PDF on NSE XBRL
Q2 FY26Consolidated3 Nov 2025PDF on NSE XBRL
Q2 FY26Standalone3 Nov 2025PDF on NSE XBRL
Q1 FY26Consolidated8 Aug 2025PDF on NSE XBRL
Q1 FY26Standalone8 Aug 2025PDF on NSE XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)88.7×
P/B7.43×
ROEFY26, on average equity4.3%
Net margin5.9%
Debt / equity0.43×
Revenue CAGR (3Y)8.4%
Profit CAGR (3Y)–
EPS (TTM)₹25.56
Market cap₹36,703 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
Balance sheet 31 Mar 2026
Total assets₹8,615 Cr+6%
Net worth₹4,940 Cr+13%
Total borrowings₹2,125 Cr+14%
Cash & bank balances₹217 Cr+94%
Investments₹412 Cr−2%
Inventories₹887 Cr+22%
Trade receivables₹588 Cr−11%
Trade payables₹563 Cr−5%
Change vs the same date a year earlier.
Shareholding 30 Jun 2026
%Jun 26Mar 26Dec 25Sept 25Jun 25Mar 25Dec 24Nov 24Sept 24Jun 24Mar 24Mar 24
Promoter49.0849.0849.0849.0849.0949.0949.0949.0951.9951.9951.6051.60
FII7.227.096.997.107.296.816.546.626.705.935.495.59
DII9.2410.9610.5511.0111.0110.599.829.885.094.454.834.83
of which MF6.798.127.767.898.02–––––––
Retail27.3125.9026.5226.1026.0426.7027.4927.4529.0230.1829.9329.85
Other public7.156.976.866.716.576.817.066.967.207.458.158.13
1,66,518 shareholders · NSE shareholding pattern filings.